Ciprofibrate (Ciprofibrate)
Overview of Ciprofibrate
Ciprofibrate is an oral lipid regulating, a fibric acid derivative with actions and uses similar to those of bezafibrate. Ciprofibrate is used in the treatment of type II a, II b, type III , and type IV hyperlipidemias.
Indication of Ciprofibrate
Ciprofibrate is primarily indicated in conditions like Hypercholesterolaemia, Hyperlipidaemias of type IIa, IIb, III and IV in patients who have not responded adequately to diet., Hyperlipidemia, Hypertriglyceridaemia.
Contraindication of Ciprofibrate
Ciprofibrate is contraindicated in conditions like Renal impairment,Hepatic impairment.
Side Effects of Ciprofibrate
Ciprofibrate produces potentially life-threatening effects which include Rhabdomyolysis, Myositis. which are responsible for the discontinuation of Ciprofibrate therapy.,The symptomatic adverse reactions produced by Ciprofibrate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Vertigo, Tiredness, Headache, Drowsiness, Nausea, Vomiting, Diarrhea, Skin rashes, Impotence, Hair loss, Increased intracranial pressure.
Precautions of Ciprofibrate
Clofibrate should not be given to patients with severe liver or kidney impairment, primary biliary cirrhosis, gallstone or gallbladder disorder or hypoalbuminaemic state.